PT Millennium Pharmacon International Tbk (ISX:SDPC) Beneish M-Score: -2.24 (As of Aug. 01, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ISX:SDPC PT Millennium Pharmacon International Tbk ISX:SDPC
79 GF Score
Price Rp181.00
GF Value Rp166.83
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is PT Millennium Pharmacon International Tbk Beneish M-Score?

PT Millennium Pharmacon International Tbk ISX:SDPC 79 Beneish M-Score is -2.24 as of Aug. 01, 2026. GuruFocus rates ISX:SDPC with a GF Score™ of 79/100 and a GF Value™ of Rp166.83 (Fairly Valued). The stock has 5 warning signs investors should review. Among 116 Medical Distribution companies, PT Millennium Pharmacon International Tbk ranks worse than 69.83% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.24 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for PT Millennium Pharmacon International Tbk's Beneish M-Score or its related term are showing as below:

ISX:SDPC' s Beneish M-Score Range Over the Past 10 Years
Min: -3.09   Med: -2.06   Max: 10.59
Current: -2.24

During the past 13 years, the highest Beneish M-Score of PT Millennium Pharmacon International Tbk was 10.59. The lowest was -3.09. And the median was -2.06.


PT Millennium Pharmacon International Tbk Beneish M-Score Historical Data

* Premium members only.

The historical data trend for PT Millennium Pharmacon International Tbk's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT Millennium Pharmacon International Tbk Beneish M-Score Chart

PT Millennium Pharmacon International Tbk Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.39 -1.90 -1.90 -2.01 -2.50

PT Millennium Pharmacon International Tbk Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.48 -2.57 -2.45 -2.50 -2.24

ISX:SDPC vs MCK, COR, CAH: Beneish M-Score Comparison

For the Medical Distribution subindustry, PT Millennium Pharmacon International Tbk's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PT Millennium Pharmacon International Tbk Beneish M-Score vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, PT Millennium Pharmacon International Tbk's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where PT Millennium Pharmacon International Tbk's Beneish M-Score falls into.


ISX:SDPC
79GF Score
PT Millennium Pharmacon International Tbk ISX:SDPC
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PT Millennium Pharmacon International Tbk Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of PT Millennium Pharmacon International Tbk for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.0267+0.528 * 0.9966+0.404 * 0.8808+0.892 * 1.0572+0.115 * 1.3128
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.0463+4.679 * 0.040405-0.327 * 1.0034
=-2.24

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Total Receivables was Rp919,316 Mil.
Revenue was 1017973.008 + 1107635.387 + 1059492.176 + 962495.396 = Rp4,147,596 Mil.
Gross Profit was 87635.621 + 105476.361 + 85489.504 + 82825.763 = Rp361,427 Mil.
Total Current Assets was Rp1,777,484 Mil.
Total Assets was Rp2,015,047 Mil.
Property, Plant and Equipment(Net PPE) was Rp87,814 Mil.
Depreciation, Depletion and Amortization(DDA) was Rp22,897 Mil.
Selling, General, & Admin. Expense(SGA) was Rp75,191 Mil.
Total Current Liabilities was Rp1,602,191 Mil.
Long-Term Debt & Capital Lease Obligation was Rp51,556 Mil.
Net Income was 10104.642 + 18083.33 + 3640.373 + 6411.45 = Rp38,240 Mil.
Non Operating Income was 0 + 0 + 0 + 0 = Rp0 Mil.
Cash Flow from Operations was -60984.545 + 71798.858 + -35321.544 + -18671.542 = Rp-43,179 Mil.
Total Receivables was Rp847,007 Mil.
Revenue was 980187.38 + 992752.887 + 983825.881 + 966552.749 = Rp3,923,319 Mil.
Gross Profit was 88567.303 + 82183.894 + 85226.951 + 84739.709 = Rp340,718 Mil.
Total Current Assets was Rp1,581,888 Mil.
Total Assets was Rp1,796,505 Mil.
Property, Plant and Equipment(Net PPE) was Rp63,045 Mil.
Depreciation, Depletion and Amortization(DDA) was Rp23,497 Mil.
Selling, General, & Admin. Expense(SGA) was Rp67,976 Mil.
Total Current Liabilities was Rp1,426,297 Mil.
Long-Term Debt & Capital Lease Obligation was Rp43,118 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(919316.484 / 4147595.967) / (847006.509 / 3923318.897)
=0.22165 / 0.21589
=1.0267

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(340717.857 / 3923318.897) / (361427.249 / 4147595.967)
=0.086844 / 0.087141
=0.9966

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (1777483.78 + 87813.771) / 2015047.454) / (1 - (1581888.102 + 63044.957) / 1796505.25)
=0.074316 / 0.084371
=0.8808

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=4147595.967 / 3923318.897
=1.0572

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(23496.866 / (23496.866 + 63044.957)) / (22897.436 / (22897.436 + 87813.771))
=0.271509 / 0.206821
=1.3128

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(75190.533 / 4147595.967) / (67976.192 / 3923318.897)
=0.018129 / 0.017326
=1.0463

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((51556.021 + 1602190.705) / 2015047.454) / ((43117.913 + 1426297.387) / 1796505.25)
=0.820699 / 0.81793
=1.0034

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(38239.795 - 0 - -43178.773) / 2015047.454
=0.040405

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

PT Millennium Pharmacon International Tbk has a M-score of -2.24 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -2.24 mean?
PT Millennium Pharmacon International Tbk (ISX:SDPC) has a Beneish M-Score of -2.24 as of Aug. 01, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on PT Millennium Pharmacon International Tbk and its competitors. According to the industry distribution chart, PT Millennium Pharmacon International Tbk ranks #81 out of 116 companies in the Medical Distribution industry, placing it in the top 69.8%.
Is PT Millennium Pharmacon International Tbk's Beneish M-Score too high?
PT Millennium Pharmacon International Tbk's current Beneish M-Score is -2.24. Based on the distribution chart, PT Millennium Pharmacon International Tbk ranks #81 out of 116 companies in the Medical Distribution industry, which is below the industry midpoint. Overall, PT Millennium Pharmacon International Tbk has a GF Score™ of 79/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does PT Millennium Pharmacon International Tbk's Beneish M-Score compare to MCK and COR?
According to the Medical Distribution industry distribution chart, PT Millennium Pharmacon International Tbk ranks #81 out of 116 companies for Beneish M-Score. This places PT Millennium Pharmacon International Tbk in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Medical Distribution company?
A good Beneish M-Score depends on the Medical Distribution industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on PT Millennium Pharmacon International Tbk and its competitors. PT Millennium Pharmacon International Tbk's current Beneish M-Score is -2.24. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Millennium Pharmacon International Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Millennium Pharmacon International Tbk (ISX:SDPC) is currently considered Fairly Valued. The stock's GF Value™ is Rp166.83, compared to a current price of Rp181.00 — trading 8.5% above its estimated fair value. The current Beneish M-Score is -2.24. PT Millennium Pharmacon International Tbk's overall GF Score™ is 79/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For PT Millennium Pharmacon International Tbk (ISX:SDPC), the current Beneish M-Score is -2.24 as of Aug. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PT Millennium Pharmacon International Tbk (ISX:SDPC) Overvalued in 2026?

Based on GuruFocus' analysis, PT Millennium Pharmacon International Tbk stock appears to be overvalued. The current stock price of Rp181.00 is trading 8.5% above its estimated GF Value™ of Rp166.83. GuruFocus considers PT Millennium Pharmacon International Tbk to be Fairly Valued.

Key valuation signals for ISX:SDPC:

  • Beneish M-Score: -2.24
  • GF Value™: Rp166.83 vs. price of Rp181.00 (8.5% above fair value)
  • GF Score™: 79/100 with 5 warning signs

No single metric tells the full story. See the ISX:SDPC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


PT Millennium Pharmacon International Tbk Business Description

Address Jl. Sultan Iskandar Muda No 18/Jl. Bungur No. 1, Crown Bungur Arteri Lantai 2-4, Kel. Kebayoran Lama Selatan, Kec. Kebayoran Lama, South Jakarta, Jakarta, IDN, 12240
PT Millennium Pharmacon International Tbk is engaged in distributing medicines, food supplements, and medical disposables. The group's operating segments are Prescription medicine, Non-prescription medicine, Medical Disposables, and others, of which the majority of revenue is derived from the Prescription Medicine segment. The company's geographical segments are Jawa, Sumatra, Kalimantan, Sulawesi, and Bali & Lombok.
79GF Score

Get the complete analysis for ISX:SDPC

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Rp181.00
Price
Rp166.83
GF Value